- Home
- INZY vs PETS Comparison
INZY vs PETS Comparison
Compare INZY & PETS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INZY
- PETS
- Stock Information
- Founded
- INZY 2015
- PETS 1996
- Country
- INZY United States
- PETS United States
- Employees
- INZY N/A
- PETS N/A
- Industry
- INZY Biotechnology: Pharmaceutical Preparations
- PETS Retail-Drug Stores and Proprietary Stores
- Sector
- INZY Health Care
- PETS Consumer Staples
- Exchange
- INZY Nasdaq
- PETS Nasdaq
- Market Cap
- INZY 64.9M
- PETS 62.8M
- IPO Year
- INZY 2020
- PETS N/A
- Fundamental
- Price
- INZY $1.15
- PETS $3.62
- Analyst Decision
- INZY Strong Buy
- PETS Sell
- Analyst Count
- INZY 9
- PETS 2
- Target Price
- INZY $17.22
- PETS $3.35
- AVG Volume (30 Days)
- INZY 1.1M
- PETS 136.4K
- Earning Date
- INZY 05-20-2025
- PETS 06-10-2025
- Dividend Yield
- INZY N/A
- PETS N/A
- EPS Growth
- INZY N/A
- PETS N/A
- EPS
- INZY N/A
- PETS 0.02
- Revenue
- INZY N/A
- PETS $247,010,000.00
- Revenue This Year
- INZY N/A
- PETS N/A
- Revenue Next Year
- INZY N/A
- PETS N/A
- P/E Ratio
- INZY N/A
- PETS $212.14
- Revenue Growth
- INZY N/A
- PETS N/A
- 52 Week Low
- INZY $0.72
- PETS $2.90
- 52 Week High
- INZY $6.24
- PETS $6.85
- Technical
- Relative Strength Index (RSI)
- INZY 50.96
- PETS 53.72
- Support Level
- INZY $1.18
- PETS $3.26
- Resistance Level
- INZY $1.63
- PETS $3.74
- Average True Range (ATR)
- INZY 0.20
- PETS 0.14
- MACD
- INZY 0.02
- PETS 0.06
- Stochastic Oscillator
- INZY 23.66
- PETS 80.95
About INZY Inozyme Pharma Inc.
Inozyme Pharma Inc is a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of diseases impacting bone health and blood vessel function. The company is focused on developing a novel therapy to treat the rare genetic diseases of ENPP1 and ABCC6 deficiencies. Its product candidate, INZ-701, is a soluble, recombinant, genetically engineered fusion protein that is designed to correct a defect in a pathway involving ENPP1 and ABCC6 deficiencies.
About PETS PetMed Express Inc.
PetMed Express Inc along with its subsidiaries is a nationwide pet pharmacy. The company markets prescription and non-prescription pet medications, health products, and supplies for dogs and cats, direct to the consumer. The company generates its revenue by selling pet medications and pet supplies mainly to retail consumers.